The family of herpesviruses encompasses more than 100 different virus types, eight of which can cause infections in humans. These so-called human herpesviruses encompass herpes simplex virus of type 1 and 2 (HSV-1 and -2), varicella zoster virus (VZV), Epstein-Barr virus (EBV), cytomegalovirus (CMV), human herpesviruses 6 and 7 (HHV-6 and -7) as well as human herpesvirus 8 (HHV-8), which is associated with Kaposi sarcoma.
For Research Use Only. Not For Use In Diagnostic Procedures.
The individual product regulatory statements may vary, please refer to the instructions for use for more information.
wdt_ID | Method | Parameter | Substrate | Species/ Antigen |
---|---|---|---|---|
626 | PCR | EURORealTime HSV-1/2 | ||
627 | IFA | antibodies against Herpes simplex virus 1 (HSV-1) IgG positive control |
||
628 | IFA | antibodies against Herpes simplex virus 1 (HSV-1) IgM positive control |
||
629 | IFA | Herpes simplex virus 1 (HSV-1) |
infected cells | EU 38 |
630 | IFA | HSV-1/HSV-2 negative control |
||
631 | WESTERNBLOT | antibodies against Herpes simplex virus (HSV) IgG positive control |
||
632 | IFA | BIOCHIP Mosaic HSV-1/HSV-2 |
2 BIOCHIPs per field: infected cells |
EU 38 |
633 | ELISA | CSQ pair of controls anti-HSV-1/2 Pool (IgG) |
||
634 | ELISA | Herpes simplex virus (HSV-1/2 Pool) |
antigen-coated microplate wells |
native antigens from HSV-1 and HSV-2 |
635 | ELISA | Herpes simplex virus (HSV-1/2 Pool) |
antigen-coated microplate wells |
native antigens from HSV-1 and HSV-2 |
636 | ELISA | Herpes simplex virus (HSV-1/2 Pool) antibody determination in CSF |
antigen-coated microplate wells |
native antigens from HSV-1 and HSV-2 |
637 | ELISA | Herpes simplex virus (HSV-1/2 Pool) incl. IgG/RF absorbent |
antigen-coated microplate wells |
native antigens from HSV-1 and HSV-2 |
638 | WESTERNBLOT | EUROLINE-WB Herpes simplex virus 1 (HSV-1) plus HSV-2 type-specific glycoprotein G2 |
Westernblot | whole antigen, SDS extract of HSV-1 plus purified gG2 |
639 | ELISA | Herpes simplex virus 1 (HSV-1) incl. IgG/RF absorbent |
antigen-coated microplate wells |
native glycoprotein C1 |
640 | ELISA | Herpes simplex virus 1 (HSV-1) |
antigen-coated microplate wells |
recombinant glycoprotein C1 |
641 | IFA | antibodies against Herpes simplex virus 2 (HSV-2) IgG positive control |
||
642 | IFA | antibodies against Herpes simplex virus 2 (HSV-2) IgM positive control |
||
643 | IFA | Herpes simplex virus 2 (HSV-2) |
infected cells | EU 38 |
644 | ELISA | Herpes simplex virus 2 (HSV-2) incl. IgG/RF absorbent |
antigen-coated microplate wells |
recombinant glycoprotein G2 |
645 | ELISA | Herpes simplex virus 2 (HSV-2) |
antigen-coated microplate wells |
recombinant glycoprotein G2 |
646 | IFA | antibodies against HHV-6 IgG positive control |
||
647 | IFA | antibodies against HHV-6 IgM positive control |
||
648 | IFA | HHV-6 | infected cells | EU 30 |
649 | IFA | HHV-6 EUROPattern | infected cells | EU 30 |
650 | IFA | HHV-6 negative control |
2024 EUROIMMUN US
Privacy Policy | Website Terms and Conditions | Cookie Notice and Settings | Consent Preferences | Sitemap